Varian Medical Systems, Inc. (NYSE:VAR) Shares Sold by Meag Munich Ergo Kapitalanlagegesellschaft MBH

Meag Munich Ergo Kapitalanlagegesellschaft MBH reduced its position in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 17.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,729 shares of the medical equipment provider’s stock after selling 1,186 shares during the period. Meag Munich Ergo Kapitalanlagegesellschaft MBH’s holdings in Varian Medical Systems were worth $763,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in VAR. CWM Advisors LLC raised its stake in shares of Varian Medical Systems by 8.0% in the 2nd quarter. CWM Advisors LLC now owns 4,788 shares of the medical equipment provider’s stock valued at $652,000 after acquiring an additional 353 shares in the last quarter. IFM Investors Pty Ltd increased its position in shares of Varian Medical Systems by 24.7% during the second quarter. IFM Investors Pty Ltd now owns 6,983 shares of the medical equipment provider’s stock valued at $951,000 after purchasing an additional 1,382 shares during the period. Raymond James Trust N.A. increased its position in shares of Varian Medical Systems by 16.7% during the second quarter. Raymond James Trust N.A. now owns 3,198 shares of the medical equipment provider’s stock valued at $435,000 after purchasing an additional 457 shares during the period. Xact Kapitalforvaltning AB increased its position in shares of Varian Medical Systems by 7.6% during the second quarter. Xact Kapitalforvaltning AB now owns 20,132 shares of the medical equipment provider’s stock valued at $2,741,000 after purchasing an additional 1,423 shares during the period. Finally, Orrstown Financial Services Inc. increased its position in shares of Varian Medical Systems by 785.3% during the second quarter. Orrstown Financial Services Inc. now owns 5,887 shares of the medical equipment provider’s stock valued at $801,000 after purchasing an additional 5,222 shares during the period. 91.03% of the stock is currently owned by hedge funds and other institutional investors.

Shares of VAR traded down $0.31 on Friday, reaching $120.78. 14,830 shares of the stock traded hands, compared to its average volume of 520,923. The firm has a market cap of $10.98 billion, a price-to-earnings ratio of 27.33, a price-to-earnings-growth ratio of 3.61 and a beta of 0.85. Varian Medical Systems, Inc. has a 12 month low of $101.42 and a 12 month high of $142.50. The stock’s 50-day moving average is $134.32.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings data on Wednesday, July 24th. The medical equipment provider reported $1.32 EPS for the quarter, topping analysts’ consensus estimates of $1.14 by $0.18. The company had revenue of $825.80 million for the quarter, compared to analyst estimates of $762.29 million. Varian Medical Systems had a return on equity of 25.24% and a net margin of 10.75%. The business’s revenue was up 16.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.04 earnings per share. Research analysts forecast that Varian Medical Systems, Inc. will post 4.64 EPS for the current year.

In other Varian Medical Systems news, insider Kolleen T. Kennedy sold 1,242 shares of the business’s stock in a transaction on Wednesday, July 10th. The stock was sold at an average price of $137.99, for a total value of $171,383.58. Following the transaction, the insider now owns 27,633 shares of the company’s stock, valued at $3,813,077.67. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP John W. Kuo sold 465 shares of the business’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $130.11, for a total value of $60,501.15. Following the completion of the transaction, the senior vice president now directly owns 35,566 shares in the company, valued at approximately $4,627,492.26. The disclosure for this sale can be found here. In the last three months, insiders sold 75,393 shares of company stock worth $10,032,731. Insiders own 0.78% of the company’s stock.

A number of analysts have recently issued reports on VAR shares. Zacks Investment Research upgraded Triple-S Management from a “hold” rating to a “buy” rating and set a $26.00 price objective on the stock in a research report on Monday, April 29th. Citigroup cut BCE from a “buy” rating to a “neutral” rating in a research report on Thursday, May 2nd. Barrington Research restated a “buy” rating and set a $142.00 price objective on shares of Varian Medical Systems in a research report on Thursday. Finally, UBS Group restated a “buy” rating and set a $124.00 price objective on shares of Cie Gnrl des Etblsmnts Michelin SCA in a research report on Thursday, April 25th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $142.44.

About Varian Medical Systems

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.

Further Reading: How is the discount rate different from the Federal Funds rate?

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.